Expression of stem cell markers CD34 and THY1 in adenocarcinoma of esophagogastric junction and their prognostic implications

被引：0
|
作者：
Aridome, Kumaki
Fiegel, Henning C.
Link, Bjoem-Christian
Bogoevski, Dean
Kaifi, Jussuf T.
Wachowiak, Robin
Kluth, Dietrich
Yekebas, Erme F.
Aikou, Takashi
Izbicki, Jakob R.
机构：
来源：
GASTROENTEROLOGY | 2006年 / 130卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A411 / A411
页数：1
相关论文
共 50 条
  • [31] Detection of cytogenetic aberrations both in CD90 (Thy-1)-positive and (Thy-1)-negative stem cell (CD34) subfractions of patients with acute and chronic myeloid leukemias
    Brendel, C
    Mohr, B
    Schimmelpfenning, C
    Müller, J
    Bornhäuser, M
    Schmidt, M
    Ritter, M
    Ehninger, G
    Neubauer, A
    LEUKEMIA, 1999, 13 (11) : 1770 - 1775
  • [32] Expression of the hematopoietic markers CD34 and c-kit in human liver epithelial stem cells
    Crosby, HA
    Hubscher, SG
    Kelly, DA
    Strain, AJ
    HEPATOLOGY, 1999, 30 (04) : 307A - 307A
  • [33] Ewing Sarcoma tumor cells express CD34: implications for autologous stem cell transplantation
    I Yaniv
    J Stein
    D Luria
    I J Cohen
    E Liberzon
    S Manor
    A Grunshpan
    Y Sverdlov
    Y Kodman
    J Issakov
    M Feinmesser
    R Zaizov
    S Avigad
    Bone Marrow Transplantation, 2007, 39 : 589 - 594
  • [34] Ewing sarcoma tumor cells express CD34: implications for autologous stem cell transplantation
    Yaniv, I.
    Stein, J.
    Luria, D.
    Cohen, I. J.
    Liberzon, E.
    Manor, S.
    Grunshpan, A.
    Sverdlov, Y.
    Kodman, Y.
    Issakov, J.
    Feinmesser, M.
    Zaizov, R.
    Avigad, S.
    BONE MARROW TRANSPLANTATION, 2007, 39 (10) : 589 - 594
  • [35] Allogeneic blood stem cell transplantation: Delayed effects of rhG-CSF treatment and stem cell apheresis on kinetics of CD34(+) cells, subsets (CD34(+) Thy-1(dim) CD38(-)) and lymphoid subsets in 10 normal donors.
    Korbling, M
    Anderlini, P
    Durett, A
    Maadani, F
    Mirza, N
    Bojko, P
    Miller, P
    Sundberg, J
    Seong, D
    Deisseroth, A
    Przepiorka, D
    Champlin, R
    BLOOD, 1995, 86 (10) : 1613 - 1613
  • [36] Detection of cytogenetic aberrations in CD 90 (Thy-1) positive and negative stem cell (CD34) subfractions of patients with acute and chronic myeloid leukemias.
    Brendel, C
    Mohr, B
    Schimmelpfennig, C
    Müller, J
    Bornhauser, M
    Ritter, M
    Ehninger, G
    Neubauer, A
    BLOOD, 1998, 92 (10) : 141B - 141B
  • [37] Delayed effects of rhG-CSF mobilization treatment and apheresis on circulating CD34(+) and CD34(+) Thy-1(dim) CD38(-) progenitor cells, and lymphoid subsets in normal stem cell donors for allogeneic transplantation
    Korbling, M
    Anderlini, P
    Durett, A
    Maadani, F
    Bojko, P
    Seong, D
    Giralt, S
    Khouri, I
    Andersson, B
    Mehra, R
    vanBesien, K
    Mirza, N
    Przepiorka, D
    Champlin, R
    BONE MARROW TRANSPLANTATION, 1996, 18 (06) : 1073 - 1079
  • [38] THE PROGNOSTIC VALUE OF THE DUAL CD34 AND CD7 EXPRESSION ON MARROW STEM CELLS AMONGE EGYPTIANT CML PATIENTS
    Ellithy, H.
    Mattar, M.
    Lasheen, A.
    Elmasry, M.
    HAEMATOLOGICA, 2014, 99 : 598 - 598
  • [39] Anomalous expression of Thy1 (CD90) in B-cell lymphoma cells and proliferation inhibition by anti-Thy1 antibody treatment
    Ishiura, Yoshihito
    Kotani, Norihiro
    Yamashita, Ryusuke
    Yamamoto, Harumi
    Kozutsumi, Yasunori
    Honke, Koichi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2010, 396 (02) : 329 - 334
  • [40] A comparison of the vascular density of VEGF expression with microvascular density determined with CD34 and CD31 staining and conventional prognostic markers in renal cell carcinoma
    Demet Yilmazer
    Ünsal Han
    Binnur Önal
    International Urology and Nephrology, 2007, 39 : 691 - 698
12345